Blinatumomab an "Eagerly Awaited New Treatment Option" for Patients With ALL
December 4th 2014The FDA has granted an accelerated approval to the anti-CD19 immunotherapy blinatumomab as a treatment for patients with Philadelphia chromosome-negative relapsed/refractory B-precursor acute lymphoblastic leukemia.
Ruxolitinib Approval Marks New Treatment Option for Patients With Polycythemia Vera
December 4th 2014The FDA has approved ruxolitinib (Jakafi) as a treatment for patients with polycythemia vera (PV) who are resistant or intolerant to hydroxyurea, marking the first treatment specifically approved for patients with PV.
For Patients With Inoperable Stage I NSCLC, Race, Hospital, and Insurance Status Matter
December 2nd 2014Despite the proven benefits of SBRT for patients with inoperable stage I NSCLC, whether such patients are offered it depends on their race, insurance status, and the type of facility where they are being treated.
The Argument For Better Patient-Centered Care in Oncology
November 26th 2014After 4 years of living with inflammatory breast cancer, Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, said she felt fine during her speech at The American Journal of Managed Care's Patient-Centered Oncology Care meeting in Baltimore, Maryland.
Groups Update Cancer Insurance Checklist to Help Patients Navigate ACA Health Exchanges
November 21st 2014With open enrollment now underway to sign up for or change their coverage under the Affordable Care Act, oncology nurses and navigators may be hearing questions from cancer patients, survivors, and their family members about navigating this still relatively new insurance marketplace.
PARP Inhibitor Demonstrates Clinical Activity in BRCA-Positive Patients
November 21st 2014The poly (ADP-ribose) polymerase (PARP) inhibitor veliparib exhibits antitumor activity and is safe and tolerable on a continuous dosing schedule when used for the treatment of patients with BRCA-positive and BRCA–wild type tumors.
Studies Forecast More CRC in Young Adults and Find Higher Mortality Among the Least Educated
November 20th 2014Findings from two studies are shining a light on demographic and socioeconomic factors impacting who will be diagnosed with colorectal cancer (CRC), who is more likely to die from it, and what preventive measures might make a difference.
ThyCa Marks 19th Year of Serving People with Thyroid Cancer
November 19th 2014According to recent estimates, approximately 62,980 people in the United States will be diagnosed with thyroid cancer in 2014, a nearly 5% increase from 2013.Thyroid cancer affects people of all ages, from young children to seniors.Its incidence is rapidly increasing among all age groups, and thyroid cancer is especially common in women, who represent three of every four people diagnosed with the disease.
Skin Care Solutions for Patients With Cutaneous Lymphoma
November 14th 2014Skin care is an important topic for every individual, but for cutaneous lymphoma patients, skin care can be the key to greatly improving your quality of life. By educating yourself about your skin, there are many things that you can do to keep your skin moisturized, soft and comfortable.
CMS to Cover Annual Lung Cancer Screening for Some High-Risk Patients
November 14th 2014The Centers for Medicare & Medicaid Services (CMS) announced that the agency plans to cover lung cancer screening using low-dose computed tomography (LDCT) for certain former and current smokers, a decision that could affect an estimated 4 million people.
Telephone Follow-Up Doubles Heart Screening Rates Among Survivors of Childhood Cancers
November 13th 2014When trained, advanced practice nurses followed up written heart screening guidelines with telephone calls to survivors of childhood cancers, screening uptake more than doubled among those who received the telephone-based counseling.
Elevating the Patient Voice: Study Finds Patients Not Prepared to Discuss Treatment Options
November 12th 2014A study released by the international nonprofit Cancer Support Community found that more than half of patients with cancer feel unprepared to discuss treatment options with their medical team, a significant finding given the high burden patients with cancer carry across a number of dimensions.
With the Right Support, Latina Breast Cancer Patients More Likely to Enroll in Clinical Trials
November 11th 2014Researchers have identified a new way to boost the enrollment of Latina patients with breast cancer in clinical trials via a culturally sensitive video, a tailored booklet, and the help of a patient navigator.
Experts Issue New Guidelines on Integrative Therapies in Breast Cancer
November 10th 2014A systematic review of published results from 203 randomized clinical trials, involving more than 80 different integrative therapies, has yielded evidence-based recommendations for clinicians and their patients with breast cancer about which of these therapies may be most helpful to manage their symptoms.
Adjuvant Breast Cancer Therapy Poses Challenges for Clinicians
November 7th 2014In May 2014, ASCO issued guidelines recommending the administration of adjuvant tamoxifen for 10 years in women with stage I-III hormone receptor (HR)-positive breast cancer, based on data from the collection of 5 clinical trials.
Clinic for Adult Survivors of Childhood Cancers One of Six in US
November 6th 2014The new Midwest Cancer Alliance Survivorship Transition Clinic is slated to open November 6-one of six adult care clinics in the country specializing in addressing long-term health issues in survivors of childhood cancer who are at high risk for late effects of their cancer treatment.
Moving Proactively to Manage AEs With Targeted Lung Cancer Therapies
November 5th 2014At the 2014 Multidisciplinary Symposium in Thoracic Oncology in Chicago, Jyoti D. Patel, MD, associate professor in Medicine-Hematology/Oncology at the Feinberg School of Medicine at Northwestern University, led a breakout session on how to manage the toxicities associated with the molecular therapies used to treat patients with lung cancers.